When was Phinomics founded?

Phinomics was founded in 2021 and raised its 1st funding round 2 years after it was founded.

Where is Phinomics located?

Phinomics is headquartered in San Carlos, United States.

How many employees does Phinomics have?

As of Jun 30, 2026, the latest employee count at Phinomics is 12.

Is Phinomics a funded company?

Phinomics is a funded company, having raised an undisclosed amount across 3 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Aug 01, 2023.

When was the latest funding round of Phinomics?

Phinomics' latest funding was a $***** Grant (prize money) round on Aug 18, 2025, with participation from 1 investor.

Where does Phinomics rank among its competitors?

Phinomics ranks 44th amongst 118 active competitors, of which 46 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Alamar Biosciences, which secured $50M in Jan, 2026.

Who are the top competitors of Phinomics?

Phinomics' top competitors include Alamar Biosciences, Personalis and Personal Genome. Among them, Alamar Biosciences secured the most recent funding round in January, 2026.

Phinomics - 2026 Company Profile, Team, Funding & Competitors

Phinomics is a funded company based in San Carlos (United States), founded in 2021 by Stephen Levene and Massa Shoura. It operates as a Developer of a genome-based technology to detect cancer. Phinomics has raised an undisclosed amount in funding. The company has 118 active competitors, including 46 funded and 18 that have exited. Its top competitors include companies like Alamar Biosciences, Personalis and Personal Genome.

Company Details

Developer of a genome-based technology to detect cancer. It provides a single-cell circular DNA-analysis technique as a genetic marker to diagnose, prevent and treat disorders driven by changes in DNA.

Website: www.phinomics.com/
Email ID: *****@phinomics.com

Key Metrics

Founded Year

2021

Location

San Carlos, United States

Stage

Funding Raised

Latest Funding Round

Grant (prize money), Aug 18, 2025, $*****

Investors

HHS & 1 more

Ranked

44^th among 118 active competitors

Employee Count

12 as on Jun 30, 2026

Similar Companies

Alamar Biosciences & 151 more

View Phinomics' full profile

Phinomics has raised funding over 3 rounds. Its first funding round was on Aug 01, 2023. Its latest funding round was a Grant (prize money) round on Aug 18, 2025 for $*****. 1 investor participated in its latest round. Phinomics has 2 institutional investors.

Here is the list of recent funding rounds of Phinomics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 18, 2025	1264366	Grant (prize money)	9691707	9408270	7802677	6702324
Mar 25, 2025	6712375	Grant (prize money)	5125220	8047579	6755987	HHS
Aug 01, 2023	1874084	Grant (prize money)	4397498	6680787	9443014	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Phinomics's funding rounds and investors

The founders of Phinomics are Stephen Levene and Massa Shoura.

Here are the details of Phinomics' key team members:

Stephen Levene: Co-Founder of Phinomics.
Contact Info: 1 email address
Massa Shoura: Co-Founder of Phinomics.
Contact Info: 1 email address

View details of Phinomics's Founder profiles and Board Members

Phinomics' employee count trend

Phinomics has 12 employees as of Jun 26. Here is Phinomics's employee count trend over the years:

Uncover Phinomics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Phinomics include Alamar Biosciences, Personalis and Personal Genome. Here is the list of Top 10 competitors of Phinomics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Alamar Biosciences 2018, Fremont (United States), Public	Provider of solutions for ultra-high sensitivity protein analysis across a range of multiplex levels	$250M	Sands Capital, Sherpa Healthcare Partners ... & 7 others	66/100
2nd	Personalis 2011, Menlo Park (United States), Public	Provider of genomic sequencing and diagnosis software for the healthcare industry	$87.3M	Lightspeed Venture Partners, Abingworth & 5 others	65/100
3rd	Personal Genome 2010, Baltimore (United States), Acquired	Provider of advanced technology solutions for cancer genome analysis	$327M	New Enterprise Associates, Camden Partners ... & 17 others	60/100
4th	Predicta Biosciences 2023, Boston (United States), Series A	Provider of diagnostic and therapeutic products for oncology	$28.6M	Engine Ventures, Myeloma Solutions Fund & 7 others	59/100
5th	Xcell Biosciences 2012, San Francisco (United States), Series B	Developer of cell culture analysis device for cancer research	$40.9M	Casdin Capital, HBM Genomics & 10 others	59/100
6th	Angle 1994, Surrey (Canada), Public	Developer of cancer cell capture and analysis equipment	-	WG Partners, Mercia & 1 others	57/100
7th	Strata Oncology 2015, Ann Arbor (United States), Series C	Precision oncology company enabling smarter cancer treatment through advanced biomarker algorithms	$139M	Merck Global Health Innovation Fund, Wellington ... & 8 others	55/100
8th	Epredia 2019, United Kingdom, Unfunded	Developer of in-vitro diagnostic test for cancer	-	-	54/100
9th	DNA Electronics 2003, London (United Kingdom), Series C	Developer of semiconductor‑based DNA‑sequencing systems for use in healthcare	-	Citi, Genting Group & 1 others	54/100
10th	PierianDx 2014, Saint Louis (United States), Acquired	Provider of genetic tests for individualized diagnosis of multiple diseases	$69.4M	ATW Partners, Orbimed & 12 others	53/100
44th	Phinomics 2021, San Carlos (United States), Funding Raised	Developer of a genome-based technology to detect cancer	-	HHS, Silicon Catalyst Angels	37/100